Neglected Tropical Diseases

Home Health and Safety Lymphadenitis: symptoms, diagnosis, treatment and prevention of lymph node infection

Nystatin cream is an antifungal, antibiotic treatment for fungal infections of the skin. It helps stop the growth of any fungi that may cause an infection. Nystatin cream is a topical ointment, which means a person should only use it on their skin and nowhere else. This article discusses the uses of nystatin cream, potential side effects, and more. Nystatin treats fungal infections on the skin. In particular, nystatin treats yeast infections of the skin resulting from a type of fungus called Candida . Candida lives in different parts of the body. Most of the time, it does not cause any issue. However, sometimes too much of the fungus grows, and an infection occurs. The most common type of Candida that causes infections is Candida albicans . While yeast infections are most common in the mouth, intestinal tract, and vagina, they can also occur on the skin. When these yeast-like infections develop on the skin, they often occur in warm, moist skin folds such as: the armpits under the bre

FARMINGTON, Conn.--( BUSINESS WIRE )--DeBogy Molecular, Inc, a biotech startup that specializes in antimicrobial surface modification, today announced the findings of a landmark in vivo research study that affirms the effectiveness and safety of their new technology to kill the dangerous bacteria that proliferates on the surface of a medical implant following surgery. Infection resulting from bacterial biofilm that forms on the surface of a medical implant represents one of the most serious complications that can follow orthopedic surgery or the implantation of a medical device. Implant related infections account for over half of the 2 million yearly healthcare-associated infections in the U.S., at a cost of over $27 billion dollars annually. A preclinical research study was conducted by Vivexia, an independent Clinical Research Organization, to evaluate the efficacy and safety of DeBogy-treated titanium implants against the formation of bacterial biofilm. A total of 121 mic

COVID-19 may not be the only respiratory infection that can result in chronic symptoms afterward. In July 2021, 9.4% of patients with COVID-19 sought treatment for symptoms that may indicate long COVID-19. According to research published in Epic Research , COVID-19 may not be the only respiratory infection that can result in chronic symptoms afterward. The study authors looked at long-lasting symptoms after 3 viral respiratory diseases: COVID-19, influenza, and viral pneumonia. However, they also analyzed symptoms reported before the acute episodes of those diseases. "We felt like there would be a certain group of people who ended up having a visit to the doctor for certain symptoms, so there would be a general rate of these visits for these types of symptoms that we were looking for," said study author Jeff Trinkl, MD, director of clinical informatics at Epic. "That would not necessarily be related to 1 of the diagnoses that we were looking for—COVID,

People queue for COVID-19 testing in Macau, China, June 20, 2022. REUTERS/John Mak June 27 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Epstein-Barr virus may play role in some long COVID cases COVID-19 may reactivate a common virus that lurks unseen in most people, and that effect might increase patients' risk of certain long-lasting symptoms, according to preliminary findings from a study. More than 90% of adults have been infected with Epstein-Barr virus (EBV). Most remained asymptomatic, but some developed mononucleosis as adolescents or young adults. Among 280 patients with SARS-CoV-2 infections, including 208 with long COVID, researchers found that at four months after diagnosis, fatigue and problems with thinking and reasoning were more common in study participants with immune cells in their blood showing signs of recent

Introduction Pseudomonas aeruginosa is a Gram-negative, rod-shaped, aerobic bacterium and one of the most common causes of infectious disease in paediatric patients, leading to high mortality. 1 It is a very common opportunistic pathogen that can normally be present on the skin of healthy individuals but may cause serious infection in the case of immunocompromised patients with haematological malignancies. 2,3 Carbapenem-resistant P. aeruginosa has been classified as a critically important pathogen by the WHO in the year 2017 because of its ability and resilience to develop antimicrobial resistance (AMR) to the most commonly used antimicrobial drugs required for life-threatening infections. Hence, new antibiotics are urgently required in order to tackle the silent pandemic of AMR. 4 The acquisition of the resistance genes and genetic mutations enables the bacterium to resist antibiotics and survive in an antibiotic enriched environment where the selection pressure for the deve

Initial symptoms of monkeypox include fever, body aches, and fatigue. The disease is similar to the smallpox virus but much less deadly. The disease can result in a rash that leads to red bumps on the skin. ​A rare condition called monkeypox has been confirmed in the United States and Europe, with more suspected cases worldwide. Although there are only about 200 confirmed cases, health experts are starting to investigate the spread and what this means for the public. Monkeypox is a virus that originated in animals in West and Central Africa. While usually confined to animals, as previous outbreaks have shown, it can also jump to humans. "This is a virus that belongs to the same group as the smallpox virus; however, it's a much milder and less deadly form of it," says Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center in Tennessee. The first confirmed case was on May 7th from a person who had traveled to the United Kingdom from Nige

Introduction Every year, about 15 million babies are born prematurely, and more than 1 million babies die due to complications of preterm birth. 1,2 A serious complication of preterm birth is neonatal respiratory distress syndrome (RDS) due to insufficient lung development and lack of surfactant production. More than half of preterm infants (born at 32 weeks of gestation or less) will develop RDS. 3 A lifesaving treatment commonly used in high-resource facilities to treat RDS is continuous positive airway pressure (CPAP) 4,5 therapy. In resource-limited settings such as low- and middle-income countries (LMICs), commercially available CPAP devices are often unaffordable, maintenance and component resupply for repair are challenging, and the required infrastructure is lacking at facility level. As an alternative, bubble CPAP (bCPAP), which is considered to be a safe and effective 6–8 therapeutic intervention, is often used to treat respiratory disease in infants and children. In